Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

Automation in Talent Attraction: fighting candidate pre-conditioning.

How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...

VILYA, Inc. Secures $71M in Expanded Series A Financing to Advance Precision Medicine

Seattle, WA, June 4, 2024 (Globe newswire) -- VILYA, Inc. (Vilya), a biotechnology company pioneering a new class of medicines with...

SERB Pharmaceuticals names Vanessa Wolfeler as CEO

Philadelphia, PA, May 30, 2024 (Globe Newswire) -- Vanessa Wolfeler will take over as CEO of SERB Pharmaceuticals on June 3, 2024....

Merck to Acquire EyeBio for Up to $3B

Rahway, NJ, and New York, May 29, 2024 (Business Wire) -- Merck is acquiring EyeBio, a biotech company focused on eye diseases, in a...

Amarin names Aaron Berg as new President and CEO

Dublin and Bridgewater, NJ, June 4, 2024 (Globe Newswire) -- Amarin's board has appointed Aaron Berg as President and CEO. Berg, who...

BD puts $4.2B towards Smart Connected Care to acquire Edwards Lifesciences' Critical Care Product Group

Franklin Lakes, NJ, June 3, 2024 (PRNewswire) -- Medical technology leader BD announced an agreement to acquire Edwards Lifesciences'...

Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in...

Atai Life Sciences Announces Leadership Transition

New York and Berlin, May 15, 2024 (Globe Newswire) -- Atai Life Sciences, a clinical-stage biopharmaceutical company, has unveiled its...

Lilly Bolsters Radiopharmaceuticals Portfolio Through $1.1B Collaboration Deal with Aktis Oncology

Indianapolis, IN, May 21, 2024 (msn.com) -- In a strategic move to bolster its presence in the radiopharmaceuticals domain, Eli Lilly...

Bolt Biotherapeutics Appoints Willie Quinn as Chief Executive Officer

Redwood City, CA, May 14, 2024 (Globe Newswire) -- Bolt Biotherapeutics, a biopharmaceutical firm headquartered in Redwood City,...

Biogen Bolsters Rare Disease Portfolio with $1.8B Acquisition of Human Immunology Biosciences

Cambridge, MA, May 22, 2024 (Reuters) -- In a strategic move aimed at reinforcing its portfolio of rare disease therapeutics, Biogen...

BridgeBio Pharma Secures $200M Private Financing to Propel Oncology Portfolio Development

Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round...